191 related articles for article (PubMed ID: 19484313)
1. A prospective trial comparing 1% lymphazurin vs 1% methylene blue in sentinel lymph node mapping of gastrointestinal tumors.
Soni M; Saha S; Korant A; Fritz P; Chakravarty B; Sirop S; Gayar A; Iddings D; Wiese D
Ann Surg Oncol; 2009 Aug; 16(8):2224-30. PubMed ID: 19484313
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of false-positive diagnosis of micrometastatic cells in the sentinel lymph nodes in colorectal cancer.
Wiese D; Saha S; Yestrepsky B; Korant A; Sirop S
Ann Surg Oncol; 2009 Aug; 16(8):2166-9. PubMed ID: 19412630
[TBL] [Abstract][Full Text] [Related]
3. Sentinel lymph node mapping of breast cancer: a case-control study of methylene blue tracer compared to isosulfan blue.
Eldrageely K; Vargas MP; Khalkhali I; Venegas R; Burla M; Gonzalez KD; Vargas HI
Am Surg; 2004 Oct; 70(10):872-5. PubMed ID: 15529840
[TBL] [Abstract][Full Text] [Related]
4. 1% lymphazurin vs 10% fluorescein for sentinel node mapping in colorectal tumors.
Dan AG; Saha S; Monson KM; Wiese D; Schochet E; Barber KR; Ganatra B; Desai D; Kaushal S
Arch Surg; 2004 Nov; 139(11):1180-4. PubMed ID: 15545563
[TBL] [Abstract][Full Text] [Related]
5. Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy.
Kargozaran H; Shah M; Li Y; Beckett L; Gandour-Edwards R; Schneider PD; Khatri VP
J Surg Res; 2007 Nov; 143(1):126-9. PubMed ID: 17950081
[TBL] [Abstract][Full Text] [Related]
6. Ultrastaging of colorectal cancer by sentinel lymph node mapping technique--a multicenter trial.
Saha S; Bilchik A; Wiese D; Espinosa M; Badin J; Ganatra BK; Desai D; Kaushal S; Singh T; Arora M
Ann Surg Oncol; 2001 Oct; 8(9 Suppl):94S-98S. PubMed ID: 11599912
[TBL] [Abstract][Full Text] [Related]
7. Methylene blue dye--a safe and effective alternative for sentinel lymph node localization.
Varghese P; Abdel-Rahman AT; Akberali S; Mostafa A; Gattuso JM; Carpenter R
Breast J; 2008; 14(1):61-7. PubMed ID: 18186867
[TBL] [Abstract][Full Text] [Related]
8. A multicenter trial of sentinel lymph node mapping in colorectal cancer: prognostic implications for nodal staging and recurrence.
Saha S; Sehgal R; Patel M; Doan K; Dan A; Bilchik A; Beutler T; Wiese D; Bassily N; Yee C
Am J Surg; 2006 Mar; 191(3):305-10. PubMed ID: 16490536
[TBL] [Abstract][Full Text] [Related]
9. Prospective comparison of peritumoral and subareolar injection of blue dye alone, for identification of sentinel lymph nodes in patients with early stage breast cancer.
Kaklamanos IG; Birbas K; Syrigos K; Bonatsos VG; Bonatsos G
J Surg Oncol; 2011 Jul; 104(1):37-40. PubMed ID: 21360537
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node evaluation does not improve staging accuracy in colon cancer.
Lim SJ; Feig BW; Wang H; Hunt KK; Rodriguez-Bigas MA; Skibber JM; Ellis V; Cleary K; Chang GJ
Ann Surg Oncol; 2008 Jan; 15(1):46-51. PubMed ID: 17985187
[TBL] [Abstract][Full Text] [Related]
11. Can methylene blue only be used in sentinel lymph node biopsy for breast cancer?
Golshan M; Nakhlis F
Breast J; 2006; 12(5):428-30. PubMed ID: 16958960
[TBL] [Abstract][Full Text] [Related]
12. Comparison of nodal positivity between SLNM vs conventional surgery in colon cancer patients with <12 and ≥12 lymph nodes harvested.
Soni M; Wiese D; Korant A; Sirop S; Chakravarty B; Gayar A; Bilchik A; Beutler T; Ratz D; Saha S
Am J Surg; 2011 Aug; 202(2):207-13. PubMed ID: 21281928
[TBL] [Abstract][Full Text] [Related]
13. Combination of ex vivo sentinel lymph node mapping and methylene blue-assisted lymph node dissection in gastric cancer: a prospective and randomized study.
Märkl B; Moldovan AI; Jähnig H; Cacchi C; Spatz H; Anthuber M; Oruzio DV; Kretsinger H; Arnholdt HM
Ann Surg Oncol; 2011 Jul; 18(7):1860-8. PubMed ID: 21503792
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer.
Thevarajah S; Huston TL; Simmons RM
Am J Surg; 2005 Feb; 189(2):236-9. PubMed ID: 15720998
[TBL] [Abstract][Full Text] [Related]
15. A new concept for the role of ex vivo sentinel lymph nodes in node-negative colorectal cancer.
Märkl B; Arnholdt HM; Jähnig H; Spatz H; Anthuber M; Oruzio DV; Kerwel TG
Ann Surg Oncol; 2010 Oct; 17(10):2647-55. PubMed ID: 20333553
[TBL] [Abstract][Full Text] [Related]
16. Intraoperative methylene blue sentinel lymph node mapping in colorectal cancer.
Chan SH; Ng C; Looi LM
ANZ J Surg; 2008 Sep; 78(9):775-9. PubMed ID: 18844907
[TBL] [Abstract][Full Text] [Related]
17. Methylene blue-assisted lymph node dissection in combination with ex vivo sentinel lymph node mapping in gastric cancer.
Märkl B; Wünsch K; Hebick KU; Anthuber M; Probst A; Arnholdt HM; Spatz H
Histopathology; 2009 Mar; 54(4):433-41. PubMed ID: 19309395
[TBL] [Abstract][Full Text] [Related]
18. Effect on oximetry of dyes used for sentinel lymph node biopsy.
Piñero A; Illana J; García-Palenciano C; Cañizarese F; Canteras M; Cañadillas V; Durán E; Parilla P
Arch Surg; 2004 Nov; 139(11):1204-7. PubMed ID: 15546820
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory cutaneous adverse effects of methylene blue dye injection for lymphatic mapping/sentinel lymphadenectomy.
Bleicher RJ; Kloth DD; Robinson D; Axelrod P
J Surg Oncol; 2009 May; 99(6):356-60. PubMed ID: 19189298
[TBL] [Abstract][Full Text] [Related]
20. Safety and technical success of methylene blue dye for lymphatic mapping in breast cancer.
Zakaria S; Hoskin TL; Degnim AC
Am J Surg; 2008 Aug; 196(2):228-33. PubMed ID: 18367146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
